BioSpace News Archive

Centrelake Medical Group, Inc. is taking action after it recently became aware that there was an incident in which an unknown third party may have gained access to the data in its practice.

Design and results from TAZPOWER and the TAZPOWER open-label extension were presented as late-breaking abstracts at the 2019 MDA Clinical & Scientific Conference

Sensient Technologies Corporation will hold its conference call to discuss 2019 first quarter results at 9:00 a.m. CDT on Wednesday, May 1, 2019.

Bioelectronic medicine scientists at The Feinstein Institute for Medical Research collaborated with counterparts from Academic Medical Center at University of Amsterdam in the Netherlands to carry out a series of pilot clinical studies to assess the effect of a novel bioelectronic stimulation.

Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc. to the securities class action pending in the United States District Court for the Northern District of California and to the June 11, 2019 Lead Plaintiff deadline.

PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab)

The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention, along with state and local officials, are investigating a multi-state outbreak of Salmonella Newport infections linked to frozen ground tuna imported into the U.S. by Jensen Tuna and sourced from JK Fish of Vietnam.

Turning Point Therapeutics, Inc. announced the pricing of its initial public offering of 9,250,000 shares of its common stock at a price to the public of $18.00 per share.

The vast majority of immune cells are found in the gut but historically, the gut has been viewed as a liability to drug development. The question of whether or not greater understanding of harnessing the gut could drive more promising drug development has led to the formation of a new company, Kintai Therapeutics.

There has been significant progress in so-called bioprinting—using a type of 3D printing to manufacture biological tissues. But an actual organ hadn’t been accomplished—until now.